The development of healthcare systems, whether medical products or Devices and pharmaceuticals, is a long and complex process that requires many R&D processes, so intellectual property rights provide the necessary incentives for industry pioneers to encourage them to innovate and cover the growing needs of this sector while protecting them from unfair competition.

• Patents, and are granted to new products and last for 20 years.
• Supplementary protection certificates (SPCs), and are obtained to extend the validity of the original patent for an additional five years.
• The Pharmaceutical Industries Regulatory Data Protection Document (RDP), and provides an eight-year protection period for use during testing periods.

• Novartis Pharmaceuticals
• Bayer Pharmaceuticals
• Pfizer Pharmaceuticals
• SPIMACO
• Sanofi Aventis